SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-289541
Filing Date
2023-12-06
Accepted
2023-12-06 07:05:32
Documents
30
Period of Report
2023-12-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d625040d8k.htm   iXBRL 8-K 25842
2 EX-99.1 d625040dex991.htm EX-99.1 21582
3 EX-99.2 d625040dex992.htm EX-99.2 20074
7 GRAPHIC g625040ex99_1s10g1.jpg GRAPHIC 125819
8 GRAPHIC g625040ex99_1s11g1.jpg GRAPHIC 102898
9 GRAPHIC g625040ex99_1s12g1.jpg GRAPHIC 137389
10 GRAPHIC g625040ex99_1s13g1.jpg GRAPHIC 120968
11 GRAPHIC g625040ex99_1s14g1.jpg GRAPHIC 93389
12 GRAPHIC g625040ex99_1s15g1.jpg GRAPHIC 96247
13 GRAPHIC g625040ex99_1s16g1.jpg GRAPHIC 24247
14 GRAPHIC g625040ex99_1s1g1.jpg GRAPHIC 69814
15 GRAPHIC g625040ex99_1s2g1.jpg GRAPHIC 231072
16 GRAPHIC g625040ex99_1s3g1.jpg GRAPHIC 91427
17 GRAPHIC g625040ex99_1s4g1.jpg GRAPHIC 116375
18 GRAPHIC g625040ex99_1s5g1.jpg GRAPHIC 105518
19 GRAPHIC g625040ex99_1s6g1.jpg GRAPHIC 89734
20 GRAPHIC g625040ex99_1s7g1.jpg GRAPHIC 100068
21 GRAPHIC g625040ex99_1s8g1.jpg GRAPHIC 96950
22 GRAPHIC g625040ex99_1s9g1.jpg GRAPHIC 93606
  Complete submission text file 0001193125-23-289541.txt   2538144

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syrs-20231206.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20231206_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20231206_pre.xml EX-101.PRE 10808
24 EXTRACTED XBRL INSTANCE DOCUMENT d625040d8k_htm.xml XML 3226
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 231468406
SIC: 2834 Pharmaceutical Preparations